Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0126187648456056 0.0106393507521774 0.00499802058590653 0.00509699129057799
Stock impact report

Apollo Therapeutics Signs Exclusive Ex-China License From Sunshine Lake Pharma for Clinical-Stage FGF21 / GLP-1 Dual Receptor Agonist, a Therapeutic With Major Commercial Potential in Mult...

FTI Consulting, Inc. (FCN) 
Last fti consulting, inc. earnings: 4/30 07:30 am Check Earnings Report
US:NYSE Investor Relations: ir.fticonsulting.com
Company Research Source: Yahoo! Finance
Both FGF21 and GLP-1 are clinically validated targets for cardio-metabolic disorders, liver disease, and related indications Dual agonist approach has potential to deliver enhanced efficacy in a range of conditions through complementary mechanisms Sunshine Lake is to receive $12m upfront and up to $926m in development, regulatory and commercial milestone payments. The commercial milestone payments are contingent upon reaching defined annual sales thresholds across major markets. In addition, Sunshine Lake stands to receive tiered royalties ranging from high single to low double digits on net sales. CAMBRIDGE, England & DONGGUAN, China, November 12, 2024 BUSINESS WIRE )--Apollo Therapeutics Group Limited ("Apollo"), the portfolio biopharmaceutical company, and Sunshine Lake Pharma Co., Ltd. ("Sunshine Lake"), an innovative pharmaceutical company and a member of HEC Group, one of the top 500 private business entities in China, have entered into an exclusive license agreement for Show less Read more
Impact Snapshot
Event Time:
FCN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for FCN alerts
Opt-in for
FCN alerts

from News Quantified
Opt-in for
FCN alerts

from News Quantified